This agreement provides funds for the implementation of the Best Pharmaceuticals for Children Act (BPCA) to support the scientific research related to pediatric therapeutics. The Best Pharmaceuticals for Children Act (BPCA) Program is a major activity for the Obstetric and Pediatric Pharmacology Branch (OPPB), a component of the Center for Research for Mothers and Children at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
